pillbase.ru

Blenrep

Active substance: belantamab mafodotin

belantamab mafodotin

Centralised EU authorisationActive

Marketing holder: GlaxoSmithKline Trading Services Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • Blenrep
    INJECTION, POWDER, FOR SOLUTION · BELANTAMAB MAFODOTIN 50 mg/mL
    0173-0913
    GlaxoSmithKline LLC
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-44d5-758c-9d70-4c6ac71aafd1;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/006511
Registration status
Active
ATC code
L01FX15
Sources
  • product · EMA · EMEA/H/C/006511 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/006511 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/006511 · Verified 2026-10-09